Novel Molecular Targets for the Treatment of Gastroenteropancreatic Endocrine Tumors: Answers and Unsolved Problems

As more knowledge on molecular alterations favoring carcinogenesis and spreading of gastroenteropancreatic endocrine tumors has become available, a number of targeted agents interfering with key growth and angiogenic pathways have been explored in preclinical and clinical studies. The mTOR inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Capurso, Gabriele, Fendrich, Volker, Rinzivillo, Maria, Panzuto, Francesco, Bartsch, Detlef K., Fave, Gianfranco Delle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565249/
https://www.ncbi.nlm.nih.gov/pubmed/23344019
http://dx.doi.org/10.3390/ijms14010030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565249/
https://www.ncbi.nlm.nih.gov/pubmed/23344019
http://dx.doi.org/10.3390/ijms14010030

Ejemplares similares